Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Morel

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
Vox Sanguinis|December 13, 2021
COVID-19 convalescent plasma: Evolving strategies for serological screening in FrancePierre Gallian, Sophie Le Cam, Nadège Brisbarre, et al.
Transfusion|December 24, 2005
Is an assay for simultaneous detection of hepatitis C virus core antigen and antibody a valuable alternative to nucleic acid testing?Syria Laperche, Marie-Hélène Elghouzzi, Pascal Morel, et al.
Transfusion|January 28, 2022
Low rate of RNAemia in blood donations collected during the first wave of COVID-19 in FranceSophie Le Cam, Pierre Gallian, Céline Ricard, et al.
Iscience|February 23, 2023
SARS-CoV-2 IgG seroprevalence surveys in blood donors before the vaccination campaign, France 2020-2021Pierre Gallian, Nathanaël Hozé, Nadège Brisbarre, et al.
Blood Transfusion = Trasfusione Del Sangue|June 1, 2021
Effectiveness of the HCV blood screening strategy through eighteen years of surveillance of HCV infection in blood donors in FrancePierre Cappy, Laure Boizeau, Daniel Candotti, et al.
Blood Transfusion = Trasfusione Del Sangue|December 18, 2015
Improving platelet transfusion safety: biomedical and technical considerationsOlivier Garraud, Fabrice Cognasse, Jean-Daniel Tissot, et al.
Viruses|November 24, 2022
Insights on 21 Years of HBV Surveillance in Blood Donors in FrancePierre Cappy, Laure Boizeau, Daniel Candotti, et al.
Transfusion|August 5, 2008
A revised method for estimating hepatitis B virus transfusion residual risk based on antibody to hepatitis B core antigen incident casesSyria Laperche, Michèle Maniez, Valérie Barlet, et al.
Emerging Infectious Diseases|November 21, 2020
Risk for Hepatitis E Virus Transmission by Solvent/Detergent-Treated PlasmaPierre Gallian, Sébastien Lhomme, Pascal Morel, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 24, 2024
New atypical epidemiological profile of parvovirus B19 revealed by molecular screening of blood donations, France, winter 2023/24Marlène Guillet, Ariane Bas, Marjorie Lacoste, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
Vox Sanguinis|December 13, 2021
COVID-19 convalescent plasma: Evolving strategies for serological screening in FrancePierre Gallian, Sophie Le Cam, Nadège Brisbarre, et al.
Transfusion|December 24, 2005
Is an assay for simultaneous detection of hepatitis C virus core antigen and antibody a valuable alternative to nucleic acid testing?Syria Laperche, Marie-Hélène Elghouzzi, Pascal Morel, et al.
Transfusion|January 28, 2022
Low rate of RNAemia in blood donations collected during the first wave of COVID-19 in FranceSophie Le Cam, Pierre Gallian, Céline Ricard, et al.
Iscience|February 23, 2023
SARS-CoV-2 IgG seroprevalence surveys in blood donors before the vaccination campaign, France 2020-2021Pierre Gallian, Nathanaël Hozé, Nadège Brisbarre, et al.
Blood Transfusion = Trasfusione Del Sangue|June 1, 2021
Effectiveness of the HCV blood screening strategy through eighteen years of surveillance of HCV infection in blood donors in FrancePierre Cappy, Laure Boizeau, Daniel Candotti, et al.
Blood Transfusion = Trasfusione Del Sangue|December 18, 2015
Improving platelet transfusion safety: biomedical and technical considerationsOlivier Garraud, Fabrice Cognasse, Jean-Daniel Tissot, et al.
Viruses|November 24, 2022
Insights on 21 Years of HBV Surveillance in Blood Donors in FrancePierre Cappy, Laure Boizeau, Daniel Candotti, et al.
Transfusion|August 5, 2008
A revised method for estimating hepatitis B virus transfusion residual risk based on antibody to hepatitis B core antigen incident casesSyria Laperche, Michèle Maniez, Valérie Barlet, et al.
Emerging Infectious Diseases|November 21, 2020
Risk for Hepatitis E Virus Transmission by Solvent/Detergent-Treated PlasmaPierre Gallian, Sébastien Lhomme, Pascal Morel, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 24, 2024
New atypical epidemiological profile of parvovirus B19 revealed by molecular screening of blood donations, France, winter 2023/24Marlène Guillet, Ariane Bas, Marjorie Lacoste, et al.
Pageof 7